Stockreport

IDEAYA Biosciences Unveils OptimUM-02 Data: Darovasertib/Crizotinib Doubles PFS in Uveal Melanoma [Yahoo! Finance]

IDEAYA Biosciences, Inc.  (IDYA) 
Last ideaya biosciences, inc. earnings: 3/24 06:00 am Check Earnings Report
PDF months (HR 0.42, p Safety was consistent with prior experience but included hypotension and syncope likely related to PKC inhibition; investigators reported management [Read more]